DNPUF (Sumitomo Pharma Co) Inventories, Other: $538 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DNPUF Sumitomo Pharma Co Ltd DNPUF
60 GF Score
Price $9.27
GF Value $5.62
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sumitomo Pharma Co Inventories, Other?

Sumitomo Pharma Co DNPUF 60 Inventories, Other is $538 Mil as of Mar. 2026. GuruFocus rates DNPUF with a GF Score™ of 60/100 and a GF Value™ of $5.62 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Sumitomo Pharma Co's other inventories for the quarter that ended in Mar. 2026 was $538 Mil.

Sumitomo Pharma Co's quarterly other inventories declined from Sep. 2025 ($560 Mil) to Dec. 2025 ($528 Mil) but then increased from Dec. 2025 ($528 Mil) to Mar. 2026 ($538 Mil).

Sumitomo Pharma Co's annual other inventories declined from Mar. 2024 ($770 Mil) to Mar. 2025 ($632 Mil) and declined from Mar. 2025 ($632 Mil) to Mar. 2026 ($538 Mil).

Sumitomo Pharma Co Inventories, Other Historical Data

* Premium members only.

The historical data trend for Sumitomo Pharma Co's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co Inventories, Other Chart

Sumitomo Pharma Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 835.08 706.28 769.93 632.12 538.27

Sumitomo Pharma Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 621.19 559.67 527.70 538.27 495.74
DNPUF
60GF Score
Sumitomo Pharma Co Ltd DNPUF
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sumitomo Pharma Co Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of $538 Mil mean?
Sumitomo Pharma Co (DNPUF) has a Inventories, Other of $538 Mil as of Mar. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Sumitomo Pharma Co and its competitors.
Is Sumitomo Pharma Co's Inventories, Other too high?
Sumitomo Pharma Co's current Inventories, Other is $538 Mil. Overall, Sumitomo Pharma Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sumitomo Pharma Co's Inventories, Other compare to ZTS?
Sumitomo Pharma Co's Inventories, Other of $538 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Drug Manufacturers company?
A good Inventories, Other depends on the Drug Manufacturers industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Sumitomo Pharma Co and its competitors. Sumitomo Pharma Co's current Inventories, Other is $538 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sumitomo Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Sumitomo Pharma Co (DNPUF) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.62, compared to a current price of $9.27 — trading 64.9% above its estimated fair value. The current Inventories, Other is $538 Mil. Sumitomo Pharma Co's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For Sumitomo Pharma Co (DNPUF), the current Inventories, Other is $538 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sumitomo Pharma Co (DNPUF) Overvalued in 2026?

Based on GuruFocus' analysis, Sumitomo Pharma Co stock appears to be overvalued. The current stock price of $9.27 is trading 64.9% above its estimated GF Value™ of $5.62. GuruFocus considers Sumitomo Pharma Co to be Significantly Overvalued.

Key valuation signals for DNPUF:

  • Inventories, Other: $538 Mil
  • GF Value™: $5.62 vs. price of $9.27 (64.9% above fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the DNPUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sumitomo Pharma Co Business Description

Address 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
60GF Score

Get the complete analysis for DNPUF

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.27
Price
$5.62
GF Value